June 3rd, 2021

Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health.

The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer Center (mskcc.org)

Transcript:

Barbra Rothschild:…

May 26th, 2021

Targeted Cancer Therapies

ON THIS PAGE

What are targeted cancer therapies?

How are targets for targeted cancer therapies identified?

How are targeted therapies developed?

What types of targeted therapies are available?

…

May 25th, 2021

Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript.

The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer…

May 16th, 2021

SAN DIEGO, Nov. 11, 2020 /PRNewswire/ –InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced updated interim results today from a Phase 1 clinical trial evaluating the efficacy and safety of…

May 8th, 2021

This coming Friday will be the Chondrosarcoma Foundation’s first anniversary. Last year, on May 14, 2020 during the beginning of the pandemic, we launched the Chondrosarcoma Foundation by bringing CS Foundation web site on-line. My…

May 7th, 2021

November 13, 2020
Dylann Cohn-Emery

Treatment with the investigation agent INBRX-109 induced responses and decreased the tumor burden in a cohort of patients with chondrosarcoma, according to interim efficacy and safety findings a phase 1 trial in…

Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year

April 30th, 2021

Elena Cojocaru,
Christopher Wilding,
Bodil Engelman,
Paul Huang &
Robin L. Jones

Current Molecular Biology Reports volume 6, pages1–9(2020)Cite this article

Is the IDH Mutation a Good Target for Chondrosarcoma Treatment? |…

Abstract

Dioxins are ubiquitous and persistent environmental contaminants whose background levels are still reason for concern. There is mounting evidence from both epidemiological and experimental studies that paternal exposure to the most potent…

Sebastien passed away July 14, 2020 from dedifferentiated chondrosarcoma. This narrative was written and submitted by his sister Stephanie Desjardins.

In April 2019, my brother was diagnosed with a chondrosarcoma of chest wall on the right side…